Dr. Atul Gawande is a surgeon, writer and public health researcher. He practices general and endocrine surgery at Brigham and Women's Hospital in Boston and is a professor at Harvard Medical School and Harvard School of Public Health. He also is executive director of Ariadne Labs, a center for health systems innovation, and chairman of Lifebox, a not-for-profit focused on making surgery safer globally. He has been a staff writer for New Yorker magazine since 1998. He previously wrote The Checklist Manifesto, and his latest book is Being Mortal: Medicine and What Matters in the End. Modern Healthcare Editor Merrill Goozner recently spoke with Gawande about how end-of-life care and long-term care can be improved through better end-of-life conversations between clinicians and patients. This is an edited transcript.
Modern Healthcare: Why did end-of-life care become so important to you?
Atul Gawande: I've been interested in the problems we have a hard time with. They range from dealing with our cost problems to understanding why we make mistakes. But a recurring theme as I've gone through more than a decade in medical practice is what it means to be good at taking care of people whose problems we cannot fix.
Our priority is keeping people healthy, but what happens when they can't be healthy? It came home to me not only with my patients, but when my dad developed brain cancer.
MH: What are the professional issues and family interactions that make this such a difficult issue?
Gawande: My father was a surgeon and my mother is a pediatrician, and we still had a hard time grappling with how to make good decisions. There are fundamental things that we fail to understand. No. 1, people have priorities besides just living longer. They have larger aims that might involve protecting their cognitive function, wanting to be home, or achieving certain life goals. The second thing is, the most reliable way to find out people's priorities is to ask them. People who have these conversations before a crisis comes tend to stop aggressive therapy when it's become purely toxic. They're more likely to enter hospice or choose therapies that enable them to be functional for longer. They have less suffering at the end of life. And the irony is that in many cases, they live longer. And we found exactly that when I tried to use those same techniques in our family conversations with my father about his priorities as his cancer was advancing.
MH: What do healthcare providers need to do to change end-of-life care?
Gawande: We should have some competence in dealing with these situations. What kind of life are we fighting for people to have, and does that match the kind of life they want? Those skills often involve some degree of practice. We also need time to have these conversations. Currently, we don't reward doctors or others for taking that time. We don't see it as a failure when we have patients reaching the end of life who've never articulated their goals or never gotten a healthcare proxy. I don't think we understand what some of those skills are. People who are really good at these conversations are more likely to ask questions than just supply facts. They tend to talk less than half of the time. When I was told that, I suddenly realized that I'm having conversations where I'm doing 90% of the talking. That's not a very successful conversation.